Zobrazeno 1 - 6
of 6
pro vyhledávání: '"miyeloproliferatif bozukluklar"'
Publikováno v:
Cukurova Medical Journal, Vol 44, Iss 1, Pp 300-302 (2019)
Externí odkaz:
https://doaj.org/article/7dad7ada9c7e420783319cbaad5b4372
Autor:
HEKİMLER ÖZTÜRK, Kuyaş, SÜLEYMAN DEMİREL ÜNİVERSİTESİ, TEPEBAŞI, Muhammet Yusuf, SULEYMAN DEMIREL UNIVERSITY, ÖZBAŞ, Halil, KOŞAR, Pınar
Publikováno v:
Volume: 28, Issue: 4 573-577
SDÜ Tıp Fakültesi Dergisi
SDÜ Tıp Fakültesi Dergisi
ObjectivePolycythemia vera (PV) is a clonal diseasecharacterized by clonal proliferation of myeloid cells.It has been shown that the Janus tyrosine kinase 2(JAK2) gene V617F mutation forms the basis of themolecular pathogenesis of the disease. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1865::8b4c5d5d5b8e790a9210df5bd2c9adfa
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96227
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96227
Publikováno v:
Volume: 28, Issue: 4 573-577
SDÜ Tıp Fakültesi Dergisi
SDÜ Tıp Fakültesi Dergisi
ObjectivePolycythemia vera (PV) is a clonal diseasecharacterized by clonal proliferation of myeloid cells.It has been shown that the Janus tyrosine kinase 2(JAK2) gene V617F mutation forms the basis of themolecular pathogenesis of the disease. In thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d0536d43ceb3f2abe98f6f8dac8ec8
https://dergipark.org.tr/tr/pub/sdutfd/issue/67913/978526
https://dergipark.org.tr/tr/pub/sdutfd/issue/67913/978526
Publikováno v:
Cukurova Medical Journal, Vol 44, Iss 1, Pp 300-302 (2019)
Volume: 44, Issue: 1 300-302
Cukurova Medical Journal
Volume: 44, Issue: 1 300-302
Cukurova Medical Journal
WOS: 000409907300005 Kronik miyeloproliferatif neoplaziler (MPN), hematopoetik kök hücreden köken alan, bir veya daha fazla miyeloid serinin anormal proliferasyonu ile karakterize hematopoetik sistemin klonal bir grup hastalığıdır. Philadelphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9477::e6d4d98a1697e232d8e0c3ac39103b18
https://hdl.handle.net/20.500.12511/3164
https://hdl.handle.net/20.500.12511/3164
Publikováno v:
Journal of Clinical and Experimental Investigations, Vol 1, Iss 2, Pp 138-140 (2010)
Volume: 1, Issue: 2 138-140
Journal of Clinical and Experimental Investigations
Volume: 1, Issue: 2 138-140
Journal of Clinical and Experimental Investigations
Dear Editor,The myeloproliferative disorders (MPDs) constitute a subcategory of chronic myeloid disorders and include chronic myeloid leukemia (CML), essential thrombocytemia (ET), polycythemia vera (PV) and myelofibrosis (MF). In 1960, the discovery